Governance Committee
The Governance Committee oversees Médicament Québec.
Mandate
- To unite the various university, college and industry stakeholders active in the pharmaceutical field;
- Identify opportunities to strengthen the main pillars funded under the grant agreement;
- Develop a strategic vision for revitalizing Quebec’s pharmaceutical industry;
- Identify innovative, multi-institutional and multi-organizational activities that could lead to collective solutions and substantial benefits for the province’s pharmaceutical industry;
- Support Médicament Québec’s strategic vision by developing complementary pillars to support the industry’s recovery;
- Develop funding avenues for research projects conducted with partners;
- Establish the operating budget;
- Propose an annual plan of activities funded by the grant;
- Approve the annual and financial reports;
- Implement and monitor activities.
Composition
The Governance Committee is chaired by Université de Montréal and its composition was approved by Quebec’s Ministry of Economy and Innovation.
| Representative of the Fonds de recherche du Québec – Santé who chairs the committee | Carole Jabet Scientific Director Fonds de recherche du Québec – Santé |
| One (1) representative of the Université de Montréal | Yves Joanette Deputy Vice-Rector Research, Discovery, Creation and Innovation Université de Montréal |
| One (1) representative from each of the participating universities | Eugénie Brouillet Vice-Rector, Research, Creation and Innovation Université Laval Jean-Pierre Perreault Vice-Rector, Research and Graduate Studies Université de Sherbrooke Philippe Gros Deputy Vice-Principal, Research and Innovation McGill University |
| One (1) representative from a college or centre for technology transfer | Nancy Déziel Executive Director National Centre in Electrochemistry and Environmental Technologies |
| Three (3) industry representatives | David Goodman Chief Executive Officer Pharmascience Inc. Therence Bois Co-founder and Chief Operating Officer Valence Discovery Frédéric Leduc Chief Scientific Officer Evolution for Animal Health |
| One (1) representative from Consortium québécois sur la découverte du médicament (CQDM) | Diane Gosselin CEO Consortium québécois sur la découverte du médicament |
| Representative(s) of the Ministry of Economy, Innovation and Energy (Observer(s)) | Marco Blouin Director General Science and Partnerships Branch Ministry of Economy, Innovation and Energy Vanessa Marsan Team leader Life Sciences Department Ministry of Economy, Innovation and Energy Yvon Fréchette Innovation Advisor Collaborative Research Department Ministry of Economy, Innovation and Energy |
| Representative of ministère de la Santé et des Services sociaux | Julie Couture Directrice Direction de la recherche et de la coordination interne Ministère de la santé et des services sociaux |
| Project Director (Observer) | Arianne Trudeau Project Director Université de Montréal |